K-pop

Leeteuk and Heechul’s Unit Super Junior-83z Releases Debut Album Today

New Group Formed by Peers Born in 1983 Features six tracks, including "A Promise for You"

KIM HYUNSIK
2026-07-13 09:27:49
[Edaily Starin KIM HYUNSIK Reporter] Super Junior-83z, a new subunit of the group Super Junior, will debut on the 13th with their first mini-album, “Promise.”
(Photo courtesy of SM Entertainment)
(Photo courtesy of SM Entertainment)
(Photo courtesy of SM Entertainment)
Super Junior-83z is a subunit formed by Super Junior members Leeteuk and Heechul, who were both born in 1983. This album features six tracks, including the title track “A Promise for You,” as well as “SOLOVE,” “Onsaemiro,” “Our Friendship Is Stronger Than Love” (More Than Love), “Bad Name,” and “GODOGNAM.”
The title track, “A Promise for You”—which shares the album’s name—is a refreshing love confession song based on the band sounds popular in the 1990s and 2000s. The music video was produced in a drama-style format, telling a story of friendship centered around the fictional No. 83 bus.
Among the album’s tracks, “Bad Name” and “GODOGNAM” are solo songs by Leeteuk and Heechul, respectively. Their agency, SM Entertainment, stated, “Leeteuk and Heechul contributed ideas throughout the entire album production process—from conceptualizing the album’s theme to writing the lyrics for the tracks and acting in the music videos—in an effort to establish a unique unit style.”

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02